Interleukin-6 (IL-6) is a pro-inflammatory cytokine produced by immune cells and other cell types such as microglia throughout the brain. Higher levels of IL-6 in older adults have been cross-sectionally and longitudinally associated with physical and cognitive impairment, as well as increased dementia risk. The association between IL-6 levels and structural and functional brain changes is less clear. In the present study, we investigated the relationship between IL-6 concentrations and cortical thinning with aging. Magnetic Resonance Imaging (MRI) scans from the Baltimore Longitudinal Study of Aging were analyzed for 121 older subjects (M = 69.3; SD = 7.3; range = 56.1 -85.9 yrs) who were repeatedly tested over an average period of 7.5 yrs, and who remained non-demented for the entire follow-up period. The Freesurfer longitudinal processing stream was utilized for image processing, and IL-6 measures were based on serum ELISA assays averaged across time points. Results showed that higher mean IL-6 concentrations were associated with accelerated annual rates of cortical thinning in the inferior temporal poles bilaterally. Additional pronounced regions of IL-6 -accelerated thinning included the transverse frontopolar gyri within the left hemisphere, and subcentral gyrus and sulcus within the right hemisphere. Our results indicate that sustained high levels of the inflammatory biomarker IL-6 are associated with regionally increased rates of age-related cortical thinning. These data build on previous findings that link to chronic disease and demonstrate one mechanism through which high levels of inflammation may have adverse effects on physical and cognitive function.
Introduction
Cytokines are small protein molecules produced by immune cells aimed at regulating several aspects of both innate and adaptive immunity.
Cytokines are also produced by a number of other cells types, including hepatocytes, adipocytes, myocytes and brain microglia, for reasons that are still not known. Interleukin-6 (IL-6) is a potent pro-inflammatory cytokine and an important mediator in any inflammatory response, so that all patients affected by overt inflammatory disease have high IL-6 levels [1] . Moreover, in inflammatory disease such as rheumatoid arthritis [2] and Crohn's disease [3] , elevated IL-6 levels are a marker of disease severity and activity.
In the absence of physiologic stress, the expression of IL-6 is normally low in young adults, but levels increase with age and with age-related disease [4] [5] [6] . Moreover, elevated levels of IL-6 have been linked to age-related cognitive decline [7] , increased dementia risk [8] , physical disability [5] and mortality [8, 9] .
Of note, the mechanism by which high levels of IL-6 are associated with high risk of physical and especially, cognitive disability have not been elucidated. For example, whether older adults with high IL-6 develop structural brain changes with age has not been investigated.
Cerebral changes such as reduced brain volumes and the thinning of gray matter are known to occur as part of the normal aging process [10] [11] [12] [13] . Withstanding the absence of age-related neurological disease, the cortex begins to experience a global thinning by middle age, with some regions such as the prefrontal cortex more affected than others [14, 15] . Importantly, structural brain changes of this nature have been linked to poorer cognitive [16] and health [17] outcomes.
In older adults, prior research has shown associations between inflammatory biomarkers and brain MRI measures. For example, IL-6 has been found to be associated with decreased total brain volume [18] , cortical atrophy [although note as part of a chemokinecytokine factor; 19], and increased white matter hyperintensities [20] . However, these findings have been based on cross-sectional associations between IL-6 and MRI measures.
In this study we aimed at expanding our understanding of the relationship between IL-6 levels and cortical brain changes in two important ways. Firstly, we assessed whether elevated IL-6 levels are associated with excessive cerebral cortical thinning over time. Secondly, whereas most of the previously cited studies have studied the relationship between IL-6 and neuroimaging at one point in time, we used longitudinal MRI data spanning on average seven and a half years, and collected in a large sample of well-characterized non-demented older adults from the Baltimore Longitudinal Study of Aging (BLSA). Given prior research indicating a primarily deleterious impact of IL-6 -indexed inflammation on brain anatomy, we hypothesized that higher sustained levels of IL-6 would be associated with a thinner cortex at baseline and an accelerated rate of cortical thinning over time.
Methods

Participants
We used data acquired from the BLSA neuroimaging study (BLSA-NI) [13] , a subset of the larger BLSA study of longitudinal changes in physical and cognitive health [21] . 
Quantification of cytokine levels
Blood serum samples for assays were used to assess peripheral inflammation levels.
IL-6 concentrations were determined using commercial ELISA kits (R&D System, Minneapolis, MN, USA) with intra and inter-assay variations of 1.6% to 4.2% and 3.3% to 6.4%, respectively. The minimum detectable level of IL-6 was less than 0.70 pg/ml. Samples were taken at approximately two years intervals and averaged across all visits (Table 1) and thickness estimates [31] . Specifically, an unbiased within-subject template space and image [32] was created using robust, inverse consistent registration [33] . Several processing steps, such as skull stripping, Talairach transforms, atlas registration as well as spherical surface maps and parcellations were then initialized with common information from the within-subject template, significantly increasing reliability and statistical power [31] . 
Mixed model analysis
The cortical thickness maps were subjected to a mixed model analysis using the AnalyzeFMRI Panel C depicts the association of IL-6 with rates of cortical thinning over time, the blue color representing areas where for every unit increase in IL-6, the cortex is thinning at an accelerated rate, the red color representing areas where for every unit increase in IL-6, the cortex is thinning at a decelerated rate. These maps are thresholded to show rates of cortical thinning at 0.001-0.008 mm per year. Panel D depicts regions where cortical thickness changes over time were statistically associated with mean IL-6, at corresponding p-values between 0.0001-0.01. Note the t-maps are for visualization purposes. Please refer to Table 2 That is, a larger surface area of gray matter was thinning at an accelerated rate with higher IL-6 levels (blue). Figure 1D This is perhaps not surprising given that neuroinflammatory evolution serves to promote both neurodegeneration and regeneration processes [36] . For example, in a large sample of adults ranging in age from 35-85 yrs, Jefferson et al. [18] found a relationship between higher IL-6 and lower total brain volume, but no relationship with white matter hyperintensities.
Results
Cortical
In another large aging study of similar sample size, Satizabal et al. [20] found positive correlations between IL-6 concentrations and white matter hyperintensities. Moreover, Baune and colleagues [19] found that IL-6
individually was not associated with either white matter hyperintensities nor a cortical atrophy rating. Nonetheless, they did find that IL-6 in combination with other cytokines Table 2 . Brain regions where higher mean IL-6 levels are associated with accelerated cortical thinning with age. Note. All coordinates are given in Talairach space. The parcellations were obtained using Destrieux sulcogyral based atlas [42] . Negative x coordinates refer to cortex in the left hemisphere, and positive x coordinates to the right hemisphere. Criterion for significance was defined as clusters with a minimum of 200 vertex, p < 0.005 with an additional cluster threshold of p < 0.05. found that IL-6 levels were linked to both higher (red on Figure 1A ) and lower (blue on Figure 1A) cortical thickness, and very few of these results reached statistical significance. At the molecular level, IL-6 plays a role in complex cognitive processes [37] , and a higher inflammatory index has been associated with reduced cognitive abilities [8] . 
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